Updated:
ANI Pharmaceuticals
ANI Pharmaceuticals is an integrated specialty pharmaceutical company developing, manufacturing, and marketing high quality branded and generic prescription...
ANI Pharmaceuticals
ANI Pharmaceuticals is an integrated specialty pharmaceutical company developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
Baudette
Corporate office
Baudette, MN, United States
Frequently asked questions
What investment posture does ANI Pharmaceuticals take toward its pipeline?
ANI operates as an operating company rather than an external allocator. It deploys balance-sheet capital primarily into acquiring Rare Disease products and optimizing manufactured generics. The company does not function as a fund or managed vehicle.
How does ANI separate its Rare Disease business from its generics operations?
ANI reports through two distinct segments: Rare Disease and Generics & Others. The Rare Disease unit pursues medicines with limited patient populations and durable exclusivity periods. The Generics unit leverages the firm's manufacturing plant in Baudette to produce a broad portfolio of solid oral and liquid prescription products.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: